The LabChip® GXII Touch System
The LabChip® GXII Touch System offers researchers an automated alternative to traditional methods by streamlining the multiple, manual steps of slab gel electrophoresis, while also providing the throughput and data quality essential in the biotherapeutics workflow.
The platform supports multiple assays for characterizing proteins in reduced and non-reduced samples including:
- Purity
- Titre
- Glycan screening
- mAb charge heterogeneity
- Fragmentation Analysis
can be performed in as few as forty seconds per sample delivering comparable data to traditional capillary electrophoresis with as much as a 70X increase in throughput. Choose 96-well or up to 384-well platforms depending upon throughput needs. Using an easy to use touch screen interface, even occasional users get up and running samples quickly. TIBCO SpotFire® data visualization further enhances data output.
PerkinElmer offers solutions to ensure the consistent, reproducible results your biotherapeutics research and patient safety considerations demand. GLP-compliant
processes in the worlds leading pharmaceutical, biotechnology and contract research organizations include our portfolio of assays and reagents, plate readers, liquid handling and technical expertise across the biotherapeutics workflow.
Further information:
http://www.genehk.com/news/doc/LabChip-GXII-Touch.pdf
http://www.perkinelmer.com/labchiptouch
Biocytogen Co Ltd
Draupnir Bio ApS